4. RESEARCHER AT THE US FOOD AND DRUG ADMINISTRATION

Related Articles Minding your $ and ¢ 1. FIRST-YEAR POSTDOC AT A LARGE UNIVERSITY 2. MID-LEVEL RESEARCHER AT A SMALL BIOTECH 3. DIRECTOR OF TOXICOLOGY AT A LARGE PHARMACEUTICAL COMPANY Economic Status: This 43-year-old man has worked at the FDA for 15 years. He makes $82,000 a year, has saved $130,000 in a government retirement plan and has more than $3,000 in checking and savings accounts. His wife is a stay-at-home mother to their two children - ages seven and three.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Economic Status: This 43-year-old man has worked at the FDA for 15 years. He makes $82,000 a year, has saved $130,000 in a government retirement plan and has more than $3,000 in checking and savings accounts. His wife is a stay-at-home mother to their two children - ages seven and three.

Financial Considerations: Planning for retirement, saving for college education, and paying all of the bills, as the sole breadwinner.

Goals: Focus on retirement first, says Linda Stratton of Stratton Advisors in Arizona. There are student loans and other assistance plans to help students with college tuition, she says, but "there's no program to help you pay for retirement." He can retire with more than one million dollars in 20 years, says Stratton by maximizing contributions to his Thrift Savings Plan (TSP), the federal employee's 401(k). Put about $4,000 a year into low-cost Roth IRA as part of his retirement ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo